On September 16-17, 2026, the Iowa Board of Regents approved the University of Iowa's new cancer drug discovery institute and advanced state funding requests for Iowa State's AI-ready innovation initiative. Simultaneously, the Board reviewed progress on the enterprise-wide REAPS revenue enhancement and efficiency initiative, signaling a system push to accelerate commercial research output while streamlining institutional operations.
Enter your email to access the complete insight library and related leads.
